May 6, 2011 – Results from an analysis of the ALTITUDE Clinical Science program demonstrated that defibrillator therapy saves lives from lethal arrhythmias without an increase in mortality due to defibrillator shock. Instead, the authors found that increased mortality risk associated with these shocks is not attributed to the defibrillator shock itself, but rather to the underlying medical condition leading to atrial and ventricular arrhythmias.
May 6, 2011 – Functionality in the echo ultrasound market drives satisfaction as providers push the bounds of what the technology can do to treat an increasing number of patients at risk for cardiovascular disease. Vendors have responded to these demands with new systems and new technology over the last couple of years.
May 5, 2011 – Volcano Corp. announced a supply agreement with ev3, a Covidien company, under which Volcano will supply its intravascular ultrasound (IVUS) technology for use in ev3's Plaque Excision Systems. Utilizing the digital IVUS transducer incorporated in Volcano's EagleEye catheter product line, this new product will be capable of running on Volcano's global installed base of 5,000 systems.
Providing exceptional cardiovascular care for patients to achieve the best possible outcomes is the number one goal for ...
May 5, 2011 – A new warranty program is available in the United States that covers Boston Scientific’s cardiac resynchronization defibrillator (CRT-D) devices and leads in the event of chronic phrenic nerve stimulation (PNS).
May 5, 2011 – GE Healthcare is showing a complete portfolio of integrated electrophysiology (EP) products featuring electrical signals recording and anatomical imaging at the lowest dose, 3-D rotational angiography capabilities, and components integration.
May 5, 2011 – GE scientists are already studying additive manufacturing techniques to reduce labor and costs on ultrasound devices. Here, the key aspect is the transducer, which is expensive to produce using current manufacturing techniques.
Cardiac positron emission tomography (PET) is growing in popularity among cardiologists because it provides the ability ...
May 4, 2011 – A new version of the Liberator Locking Stylet uses a distinct radiopaque tip marker to increase radio-opacity under fluoroscopy.
May 4, 2011 – Doctors should consider using catheterization as a treatment tool in addition to its established role in diagnosing children with heart defects, according to a new American Heart Association scientific statement.
May 4, 2011 – At Heart Rhythm 2011, the Heart Rhythm Society’s 32nd annual scientific sessions in San Francisco, Royal Philips Electronics and the Heart Rhythm Society (HRS) have teamed up to showcase current solutions and future developments that shape the diagnosis and minimally invasive treatment of heart rhythm disorders.
When performing radiofrequency (RF) ablation to treat cardiac arrhythmia, medical professionals must balance the safety ...
May 4, 2011 – Endosense and Siemens Healthcare have completed a prototype software software software integrating the contact-force data provided by Endosense’s TactiCath force-sensing ablation catheter1 with Siemens’ electrophysiology solutions.
May 3, 2011 – The U.S. Food and Drug Administration (FDA) has given 510(k) clearance to Maquet Cardiovascular’s Cardiohelp system as a cardiac and/or respiratory assist device for up to six hours. The system is the world's smallest portable heart-lung support system providing extracorporeal life support (ECLS) to replace or support a patient's circulation and respiration.
New guidelines review strengths of current imaging modalities and make recommendations for using them to optimize patient management.
Change Healthcare Cardiology Hemodynamics is an integrated hemodynamic monitoring system for monitoring vital signs and ...
A new version of the Lifepak 15 monitor/defibrillator is designed to help hospital, as well as pre-hospital, teams provide more effective patient care. The 15, when used together with CODE-STAT data review software and the Lifenet system data network, empowers hospital and pre-hospital care teams with a powerful new suite of tools that utilize patient, performance and device data to improve care, trim operational costs and streamline equipment management.
May 3, 2011 – Being tall and obese may increase your risk for potentially dangerous blood clots, according to new research in Arteriosclerosis, Thrombosis and Vascular Biology: Journal of the American Heart Association.
May 3, 2011 – European CE mark approval was granted and the first use announced for the Blazer open-irrigated radiofrequency (RF) ablation catheter. The Boston Scientific catheter is designed to treat a variety of arrhythmias such as atrial fibrillation, atrial flutter, ventricular tachycardia and other supraventricular tachycardias. The product is being launched this quarter in select CE mark countries.